Hugo Biotech

Hugo Biotech

Private
Beijing, BeijingHealthcare & Life Scienceswww.hugobiotech.com

Last Round

Grant

Nov 1, 2024

Total Funding Raised

$127.2M

Company Overview

Hugo Biotech is a biotechnology company specializing in high-throughput microbial sequencing technology that enables rapid and precise identification of pathogenic microorganisms in clinical samples through advanced DNA and RNA sequencing, eliminating the need for culturing and specific amplification methods.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Healthcare Analytics, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Data as a Service

AI Layer

Application

Keywords

metagenomic sequencingmNGSpathogen detectioninfectious disease diagnosticsgenomic data analysishigh-throughput sequencingnext-generation sequencingNGSbioinformaticsclinical diagnosticssequencing servicesculture-free diagnosticspathogen genomicslaboratory servicesTB diagnostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hugo Biotech Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Hugo Biotech Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantNov 1, 2024
Series CJan 21, 2022
Series BJul 20, 2021
Series ASep 28, 2020
Series A ExtensionJun 29, 2020
Seed
Aug 1, 2019

Key People

Founding team and executive leadership

Han Xia

CEO Founder At HugoBiotech

Founding Team

Hugo Biotech Investors

Notable investors and investment history

Hugo Biotech Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Hugo Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hugo Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing, Beijing
Employee Range5
Year Founded2017
Last FundingNov 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.